Clenbuterol

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

β2 sympathomimetic.

IndicationThis section has been translated automatically.

Bronchial asthma, emphysema.

Limited indicationThis section has been translated automatically.

Mitralvitium, myocarditis, tachyarrhythmia, WPW syndrome, liver or kidney failure, hypokalemia.

Dosage and method of useThis section has been translated automatically.

1-3 times/day 0.01 mg or 2 times 0.02 mg p.o. or 2-3 times/day 4-7 trp. per inhalation.

Undesirable effectsThis section has been translated automatically.

Contraction inhibition, hyperhidrosis, pruritus, muscle cramps, blood pressure increase, hyperglycaemia, hypokalemia, paradoxical bronchospasms, micturition disturbance.

ContraindicationThis section has been translated automatically.

Narrow-angle glaucoma, pheochromocytoma.

PreparationsThis section has been translated automatically.

Spiropent

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer